<style type="text/css"> .wpb_animate_when_almost_visible { opacity: 1; }</style>

INVESTOR RELATIONS

Dr. Rodney S. Markin

Committees: Executive Compensation Committee, Audit Committee, Corporate Governance and Nominating Committee

Dr. Markin has been a director of Trovagene since February 2014.  Dr. Markin is Chief Technology Officer and Associate Vice Chancellor for Business Development at the University of Nebraska Medical Center and a Professor of Pathology and Microbiology; David T. Purtilo Distinguished Professor Pathology and Microbiology and Courtesy Professor of Surgery. Dr. Markin is also a director on the Board of Children’s Hospital and Medical Center Foundation and on the Board of Trustees for Keck Graduate Institute. Dr. Markin is Chairman of the Board of Transgenomic, Inc., a biotechnology company.  The Board selected Dr. Markin to serve as a director because he has valuable executive experience in the healthcare business.


email print